NCT00908050View on ClinicalTrials.gov

Study of the Safety and Efficacy of Botox in Bruxism

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

August 31, 2011

Study Completion Date

September 30, 2011

Conditions
Bruxism
Interventions
DRUG

Botulinum toxin type A

Patients are injected with botulinum toxin type A (BOTOX) 60 units in each masseter muscle and 35 in each temporalis muscle, bilaterally.

DRUG

Placebo arm

Placebo comparator

Trial Locations (1)

77030

Baylor College of Medicine, Houston

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Baylor College of Medicine

OTHER